Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Potassium Correction for Renin-angiotensin-aldosterone System Optimization in Chronic Kidney Disease

NCT06256991 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT06256991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06256991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Potassium Correction for Renin-angiotensin-aldosterone System Optimization in Chronic Kidney Disease
Lead sponsor
University Medical Center Groningen
Phase
Phase 4
Overall status
Recruiting
Start date
April 1, 2024
Completion date
December 31, 2027
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases, hyperkalemia, hypertension